GERRESHEIMER AG (GXI.DE) Stock Price, Forecast & Analysis
Europe - Frankfurt Stock Exchange - FRA:GXI - DE000A0LD6E6 - Common Stock
GXI.DE Key Statistics, Chart & Performance
The current stock price of GXI.DE is 26.9 EUR. In the past month the price increased by 8.21%. In the past year, price decreased by -62.19%.
GXI.DE Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 56S1.DE | SARTORIUS STEDIM BIOTECH | 47.96 | 20.12B | ||
| DIM.PA | SARTORIUS STEDIM BIOTECH | 47.77 | 20.04B | ||
| SRT3.DE | SARTORIUS AG-VORZUG | 53.84 | 18.38B | ||
| SRT.DE | SARTORIUS AG | 41.54 | 14.18B | ||
| QIA.DE | QIAGEN N.V. | 19.4 | 8.45B | ||
| 1SXP.DE | SCHOTT PHARMA AG& CO KGAA | 15.36 | 2.24B | ||
| EVT.DE | EVOTEC SE | N/A | 1.91B | ||
| FF.MI | FINE FOODS & PHARMACEUTICALS | 10.76 | 211.33M | ||
| ALECR.PA | EUROFINS CEREP-REGR | 24.9 | 178.00M | ||
| MLC.I | MALIN CORP PLC | N/A | 33.34M |
Related stock screener links
About GXI.DE
Company Profile
Gerresheimer AG engages in the manufacturing and supplies glass and plastic products for the pharmaceutical and healthcare industry. The company is headquartered in Dusseldorf, Nordrhein-Westfalen and currently employs 13,535 full-time employees. The company went IPO on 2007-06-11. The company operates through two business segments: Plastics and Devices, and Primary Packaging Glass. The Plastics and Devices segment produces standard and customized products for drug delivery, such as insulin pens, inhalers, and prefillable syrings. The Primary Packaging Glass segment focuses on the production of packaging of glass for medicines and cosmetics, such as pharmaceuticals jars, ampoules, injection vials, cartridges, perfume flacons and cream jars, as well as glass containers for the food and beverage industry. The firm operates approximately 40 production facilities in Europe, North America, South America and Asia.
Company Info
GERRESHEIMER AG
Klaus-Bungert-Strasse 4
Dusseldorf NORDRHEIN-WESTFALEN DE
Employees: 13535
Phone: 49211618100
GERRESHEIMER AG / GXI.DE FAQ
What does GERRESHEIMER AG do?
Gerresheimer AG engages in the manufacturing and supplies glass and plastic products for the pharmaceutical and healthcare industry. The company is headquartered in Dusseldorf, Nordrhein-Westfalen and currently employs 13,535 full-time employees. The company went IPO on 2007-06-11. The company operates through two business segments: Plastics and Devices, and Primary Packaging Glass. The Plastics and Devices segment produces standard and customized products for drug delivery, such as insulin pens, inhalers, and prefillable syrings. The Primary Packaging Glass segment focuses on the production of packaging of glass for medicines and cosmetics, such as pharmaceuticals jars, ampoules, injection vials, cartridges, perfume flacons and cream jars, as well as glass containers for the food and beverage industry. The firm operates approximately 40 production facilities in Europe, North America, South America and Asia.
What is the stock price of GERRESHEIMER AG today?
The current stock price of GXI.DE is 26.9 EUR. The price decreased by -2.68% in the last trading session.
Does GERRESHEIMER AG pay dividends?
GERRESHEIMER AG (GXI.DE) has a dividend yield of 0.15%. The yearly dividend amount is currently 1.32.
What is the ChartMill technical and fundamental rating of GXI stock?
GXI.DE has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Would investing in GERRESHEIMER AG be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on GXI.DE.
Is GERRESHEIMER AG (GXI.DE) expected to grow?
The Revenue of GERRESHEIMER AG (GXI.DE) is expected to grow by 13.08% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
How many employees does GERRESHEIMER AG have?
GERRESHEIMER AG (GXI.DE) currently has 13535 employees.
GXI.DE Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to GXI.DE. When comparing the yearly performance of all stocks, GXI.DE is a bad performer in the overall market: 96.74% of all stocks are doing better.
GXI.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to GXI.DE. GXI.DE has a bad profitability rating. Also its financial health evaluation is rather negative.
GXI.DE Financial Highlights
Over the last trailing twelve months GXI.DE reported a non-GAAP Earnings per Share(EPS) of 3.69. The EPS decreased by -19.08% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 1.04% | ||
| ROA | 0.5% | ||
| ROE | 1.67% | ||
| Debt/Equity | 1.22 |
GXI.DE Forecast & Estimates
23 analysts have analysed GXI.DE and the average price target is 38.55 EUR. This implies a price increase of 43.31% is expected in the next year compared to the current price of 26.9.
For the next year, analysts expect an EPS growth of -33.84% and a revenue growth 13.08% for GXI.DE